Intervention Protocol

Interventions for melanoma in situ, including lentigo maligna

  1. Zoe Apalla1,*,
  2. Thrasivoulos Tzellos2,
  3. Athanassios Kyrgidis3,4,5,
  4. Simone Mocellin6,
  5. An-Wen Chan7,
  6. Shaheen Haque Hussain8,
  7. Pierluigi Pilati6

Editorial Group: Cochrane Skin Group

Published Online: 31 JAN 2013

DOI: 10.1002/14651858.CD010308


How to Cite

Apalla Z, Tzellos T, Kyrgidis A, Mocellin S, Chan AW, Haque Hussain S, Pilati P. Interventions for melanoma in situ, including lentigo maligna (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD010308. DOI: 10.1002/14651858.CD010308.

Author Information

  1. 1

    Hospital of Skin and Venereal Diseases, State Clinic of Dermatology, Thessaloniki, Greece

  2. 2

    Faculty of Health Sciences, University Hospital of Northern Norway, Department of Dermatology, Harstad, Troms, Norway

  3. 3

    Dessau Medical Center, Division of Evidence Based Dermatology, Dessau, Germany

  4. 4

    Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Dermatology and Skin Cancer Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy

  5. 5

    Aristotle University of Thessaloniki, Otolaryngology Head & Neck Surgery, Thessaloniki, Greece

  6. 6

    University of Padova, Meta-Analysis Unit, Department of Surgery, Oncology and Gastroenterology, Padova, Veneto, Italy

  7. 7

    University of Toronto, Women's College Research Institute, Toronto, ON, Canada

  8. 8

    Addenbrooke's Hospital, Department of Dermatology, Cambridge, UK

*Zoe Apalla, State Clinic of Dermatology, Hospital of Skin and Venereal Diseases, 17, Omirou street, Thessaloniki, 55535, Greece. zoimd@yahoo.gr.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 31 JAN 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of all available interventions, surgical and non-surgical, for the treatment of melanoma in situ, including lentigo maligna. We also aim to assess efficacy, harms, and tolerability of postoperative adjuvant therapies after surgical treatment, as well as the efficacy, harms, and tolerability of non-surgical interventions preoperatively (neoadjuvant therapies), in order to facilitate surgical removal.